2POB

PPARgamma Ligand binding domain complexed with a farglitazar analogue gw4709


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.30 Å
  • R-Value Free: 0.273 
  • R-Value Work: 0.225 
  • R-Value Observed: 0.226 

wwPDB Validation 3D Report Full Report


This is version 1.3 of the entry. See complete history


Literature

Cocrystal structure guided array synthesis of PPARgamma inverse agonists

Trump, R.P.Cobb, J.E.Shearer, B.G.Lambert, M.H.Nolte, R.T.Willson, T.M.Buckholtz, R.G.Zhao, S.M.Leesnitzer, L.M.Iannone, M.A.Pearce, K.H.Billin, A.N.Hoekstra, W.J.

(2007) Bioorg Med Chem Lett 17: 3916-3920

  • DOI: 10.1016/j.bmcl.2007.04.111
  • Structures With Same Primary Citation

  • PubMed Abstract: 
  • PPARgamma-activating thiazolidinediones and carboxylic acids such as farglitazar exert their anti-diabetic effects in part in PPARgamma rich adipose. Both pro- and anti-adipogenic PPARgamma ligands promote glucose and lipid lowering in animal models ...

    PPARgamma-activating thiazolidinediones and carboxylic acids such as farglitazar exert their anti-diabetic effects in part in PPARgamma rich adipose. Both pro- and anti-adipogenic PPARgamma ligands promote glucose and lipid lowering in animal models of diabetes. Herein, we disclose representatives of an array of 160 farglitazar analogues with atypical inverse agonism of PPARgamma in mature adipocytes.


    Organizational Affiliation

    Drug Discovery, GlaxoSmithKline, Research Triangle Park, NC 27709, USA.



Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Peroxisome proliferator-activated receptor gamma
A, B
272Homo sapiensMutation(s): 0 
Gene Names: PPARGNR1C3
Find proteins for P37231 (Homo sapiens)
Go to UniProtKB:  P37231
NIH Common Fund Data Resources
PHAROS  P37231
Protein Feature View
  • Reference Sequence
Small Molecules
Ligands 2 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
GW4
Query on GW4

Download CCD File 
A
N-[(2S)-2-[(2-BENZOYLPHENYL)AMINO]-3-{4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL}PROPYL]ACETAMIDE
C36 H35 N3 O4
WCJXONGEWJNZQV-PMERELPUSA-N
 Ligand Interaction
GOL
Query on GOL

Download CCD File 
B
GLYCEROL
C3 H8 O3
PEDCQBHIVMGVHV-UHFFFAOYSA-N
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
GW4Ki:  138   nM  BindingDB
GW4EC50:  1000   nM  BindingDB
GW4IC50:  1585   nM  BindingDB
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.30 Å
  • R-Value Free: 0.273 
  • R-Value Work: 0.225 
  • R-Value Observed: 0.226 
  • Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 92.916α = 90
b = 62.006β = 101.94
c = 118.172γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
MAR345data collection
HKL-2000data reduction
HKL-2000data scaling
AMoREphasing

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

  • Deposited Date: 2007-04-26 
  • Released Date: 2008-03-18 
  • Deposition Author(s): Nolte, R.T.

Revision History 

  • Version 1.0: 2008-03-18
    Type: Initial release
  • Version 1.1: 2011-07-13
    Changes: Non-polymer description, Version format compliance
  • Version 1.2: 2014-09-10
    Changes: Database references
  • Version 1.3: 2017-10-18
    Changes: Refinement description